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Abstract 
Nearly 40% of novel drugs comes in pharmaceutical industries are showing poor capability of 
solubilization in water. Therefore enhancing the solubilization of such drugs in water to 
enhance their bioavailability be the major challenge to formulation scientists. So the 
preparation of solid dispersion from the drug which shows poor solubility in water with 
carriers having good water solubility has decrease the occurrence of such problems and 
increase dissolution. Hence solid dispersion found to be attention-grabbing method for 
solubility enhancing of drugs which showing poor solubility in water. This review, shows an 
overview on the different solid dispersion types, rationale, their advantages, limitations, 
manufacturing processes as well as its characterization methods. 
Introduction
The most simple, easy and convenient path drug 
administration is through the oral route of administration 
due to its better stability, dose accuracy, lesser bulk and 
easy manufacturing.(1,2) Mainly the bioavailability of 
drugs from oral route depends on their solubility as well 
as permeability. On the basis of this two parameter drugs 
are classified into the four classes which known as 
Biopharmaceutical Classification System (BCS) which 
are mention below (3,4,5) 
Table no.1: BCS classification 
BCS 
Class 
Solubility in 
aqueous 
environment 
Permeation over 
(intestinal) 
membrane 
Class I High soluble High permeable 
Class 
II 
Low soluble High permeable 
Class 
III 
High soluble Low permeable 
Class 
IV 
Low soluble Low permeable 
Nearly 40% from the novel drugs in pharmaceutical 
industries shows poor solubility in water.(1,6) Therefore 
major problems of these drugs is their poor 
bioavailability due to its poor water solubility.(7) Hence 
dose of drug require larger to produce therapeutic effect 
which may produce toxic effect of these drug.(1) If 
drugs in gastrointestinal area shows incomplete release, 
it will show a less bioavailability and it is essential to 
enhance the solubility alternatively  increases dissolution 
rate of such drugs to improve its bioavailability.(8) 
Noyes Whitney equation, which gives some hints of 
different parameters which may helpful in enhancing  
the bioavailability of the poorly soluble drugs. 
 
Dc/Dt= AD(Cs-C)/ h 
 
where, dc/dt- is the rate of dissolution  
A- Surface area available for dissolution  
D- Diffusion coefficient of the compound  
Cs- solubility of the compound in the dissolution 
medium  
C- Concentration of drug in the medium at time t  
h- Thickness of diffusion boundary layer adjacent to the 
surface of dissolving compound. (9,10,11) 
 Various techniques for Solubility Enhancement (1,5,12,13, 
14,15) 
1) Physical Modifications 
i. Particle size reduction 
ii. Complexation 
iii. Modification of the crystal habit 
iv. Drug dispersion in carriers 
            a. Solid solution 
            b. Eutectic mixtures 
            c. Solid dispersion 
   v.      Solubilization by surfactants 
2) Chemical Modification 
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i. Salt Formation 
ii. Solubilizing agent   
iii. Co-solvency 
iv. Co-crystallization 
v. Nanotechnology 
vi. Hydrotropic 
3) Other: 
i. Hot melt extrusion 
ii. High- Pressure Homogenization 
iii. Solvent evaporation method 
iv. Polymeric Alteration 
v. Supercritical fluid method 
vi. Electrostatic spinning method 
vii. Spray freezing into liquid and Lyophillization 
viii. Lyophilization technique 
ix. Evaporative precipitation into aqueous solution 
x. Direct capsule filling 
xi. Inclusion Complexes: 
a. Kneading Technique 
            b. Co-precipitation 
c. Spray-Drying Method 
Solid Dispersion 
Various technique were used for enhancement of drug 
solubility consequently the dissolution rate and 
bioavailability of drug. Among this the solid dispersion 
is common technique used to enhancing the drug 
solubility. Many solid dispersion formulation have been 
formulated since from the 1960’s.(1,16) In 1961, a 
method which shows promising enhancement in 
bioavailability of drug which shows poor solubility in 
water was developed by Obi and Sekiguchi. Later on it 
known as solid dispersion which involve preparation of 
eutectic mixture of drug with carrier which gives 
solubility in water.(15) In 1971, Chiou and Reigelman, 
first defined solid dispersion as “dispersion of one or 
more active ingredients in an inert carrier or matrix 
(hydrophilic) at solid state prepared by fusion, solvent or 
melting solvent method.”(9,16) 
Table no.2:Example of commercial product prepared 
by using solid dispersion technology(2,17,18) 
Product 
name 
Drug 
Carrier 
molecule 
Technique 
for 
preparation 
Orkambi Lumacaft HPMCAS/SLS 
Spray 
drying 
Novir Ritonavir PVP-VA 
Melt 
extrusion 
Onmel traconazole HPMC 
Melt 
extrusion 
Samsca Tolvaptan N/A Granulation 
Gris-
PEG 
Griseofluvin HPMCAS/SLS 
Spray 
drying 
 
HPMC—hydroxypropyl methylcellulose; HPMCAS—
hydroxypropyl methylcellulose acetate 
succinate;PVPVA— povidone-vinyl acetate 
(copovidone); SLS—Sodium Lauryl sulfate; N.A.—Not 
available; 
Classification of Solid Dispersion(6,11,14,19,20,21) 
Solid dispersion are classified on basis of 
A] Their molecular arrangement 
B] Carrier used for solid dispersion 
A] Their molecular arrangement 
 In this solid dispersion again subdivided into the 
subsequent six types on the basis of its molecular 
arrangement. 
1) Simple eutectic mixture 
2) Amorphous precipitations in crystalline matrix 
3) Solid solutions 
a) Continuous Solid Solutions  
b) Discontinuous solid solutions 
c) Substitutional solid  solutions 
d) Interstitial solid solutions 
4) Glass suspension  
6) Glass solution  
1) Simple eutectic mixture 
It is first described by Sekiguchi& Obi in1961 as solid 
dispersion.(19) It is formed by rapid solidification of 
miscible  molten state of drug and polymer which shows 
negligible miscibility when they crystallize just like two 
distinct components on their cooling.(1,19) Both drug and 
polymer exist in crystalline state.(14) It shows the 
enhanced  release because the drug dispersion found as 
fine crystals and increase in wetting due to the carrier 
presence, in some cases dissolved drug solubilization 
occurs in some cases. (18) 
2) Amorphous precipitations in crystalline matrix 
It is same as simple eutectic mixture only difference in 
this is that the drug occurs in precipitated form instead of 
the crystalline form. (1) 
3) Solid solutions 
This is defined as a solid dispersion which is miscible 
not only in its solid state but also in their fluid state. The 
solid solutions either be of crystalline or amorphous 
type.(19) Solid solution shows better dissolution rate 
compare to the eutectic mixture due to  reduction occurs 
in particle size of the drug. In this rate of dissolution is 
depend on the rate of dissolution of carrier.(10) Solid 
solutions subdivided into the two methods based on the 
i) miscibility extent of two components and ii) 
distribution way of solvate molecules in the 
solvendum.(1,6) 
i) Miscibility extent of two components 
It either be   a) Continuous type b) Discontinuous type 
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a) Continuous type 
It concern about the miscibility in the solid state of two 
component is in all proportions which mean that the 
individual components strength of bonding is weaker 
than that of the two components strength of bonding.(1) 
 
 
Fig. no.1:Classification of Solid dispersion 
 
b) Discontinuous type 
It concern that each of the components had limited 
solubility in the other component.  On the basis of 
Goldberg et al. suggestion the term `solid solution' can 
be applicable only when the two components mutual 
solubility exceeds 5%.(6,11,18) 
ii) Distribution way of solvate moleculesin the 
solvendum 
It may a) Substitutionalsolid  solutions or b) Interstitial 
solid solutions 
a) Substitutional solid solution  
In this, the solvent molecule substitutes by the solute 
molecule in the crystal lattice.(19) For such substitution 
the particle size of solute molecule differ by not more  
than 15% than that of solvent molecule.(6,11) 
b)  Interstitial solid solutions 
In such solid solutions the interstitial space in the solvent 
lattice occupies by the solute molecule.(18,19) In such 
cases  the difference between the diameters of solute 
molecule and solvent molecule should be not more than 
0.59 times.(6,11) 
4) Glass suspension and solution 
The mixture containing suspended precipitated particles 
in a glassy solventis known as glass suspension and 
glass solution forms homogeneous glassy system by 
dissolving the solute molecule in glass carrier. (1,6) 
Carriers that are used for the preparation of glass 
solutions are sugars, like galactose, dextrose, trehalose, 
fructose or amorphous polymers like HPMC, Polyvinyl-
pyrrolidone-co-vinylacetate (PVPVA) and PVP.(18) A 
pure chemical or a mixture of pure chemicals in the 
glassy state refer as glass. (9)  The lattice energy which 
act as barrier in dissolution is much greater in solid 
solution than the glass solution. Brittleness and 
transparency below the glass transition temperature is 
the characteristic of glassy state. (1) 
B] Carrier used for solid dispersion (1,6,8,9,16,19,20,21,22,23)
 
1) First generation 
2) Second generation 
3) Third generation 
4) Fourth generation 
1) First generation 
These type of solid dispersions were formed by using the 
crystalline carriers such as sugar, urea and mannitol. 
(9,21) It is mainly concern with the concept of eutectic 
mixture which were described by Sekiguchi and Obi in 
1961.(1)The first generation solid dispersion posses the 
good thermodynamical stability due to crystalline carrier 
and it shows less solubility as compare to the amorphous 
form which lead as a main disadvantage of first 
generation solid dispersion.(16,22) 
2) Second generation 
In the late sixties it was observed that solid dispersions 
of crystalline form of drug was less efficient than 
amorphous form of drug because of their high 
thermodyanamical stability. Hence the second 
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generation solid dispersion appeared which contain 
amorphous carriers rather than the crystalline carriers 
which are mostly polymers. (8,21) These polymeric 
carrier includes synthetic polymers like 
polyethyleneglycols (PEG),  polymethacrylates and 
povidone (PVP)  and natural polymers like cellulose 
derivatives, such as hydroxypropylmethylcellulose, 
hydroxypropylcellulose or ethylcellulose and starch 
derivates, such as cyclodextrins 21.(6,9) In second 
generation because of forced solubilization, the drug 
found at its supersaturated state in carrier.(8,16) 
Amorphous solid dispersions on the basis of molecular 
interaction of carrier and drug are classified as solid 
solutions, solid suspension or mixture of both. Examples 
amorphous carriers are polyvinylacetate, 
polyethyleneglycol, polymethacrylate, cellulose 
derivatives, povidone,.(1) 
3) Third generation 
Third generation solid dispersion appeared  because  it 
was seen that if the carrier shows any surface activity or 
self-emulsifying properties the dissolution rate of drug is 
increases.(19) Hence solid dispersion contain a 
surfactant or a mixture of polymers and surfactants as 
carriers which shows improve dissolution rate of poorly 
soluble drugs ultimately shows increase in 
bioavailability such drugs.(9) The surfactants as  carriers 
include poloxamer , compritol 888 ATO, , inutec SP1  
and soluplus. Other surfactants and emulsifiers such as 
sodium lauryl sulfate (SLS), Tween 80 ,polyoxyethylene 
hydrogenated sucrose laurate and castor oil.(21) The 
drawback of solid dispersion like precipitation and 
recrystallization was avoided due to incorporation of 
surface active carrier or self-emulsifing carriers. It also 
shows improvement in the drug stability.(8,20,21) 
4) Fourth generation   
It is mainly concern with solid dispersion having 
controlled release of poor water-soluble drugs with a 
short biological half-life. It has two targets: enhancement 
in solubility and prolonged release with controlled 
manner. In CRSD, drug can be released by two 
mechanism: diffusion and erosion. Drug release retarded 
polymer in CRSD include ethyl cellulose (EC), HPC, 
poly(ethylene oxide) (PEO) and Eudragit RS RL  (21) 
Rationale for using solid dispersion technique(16) 
➢ To enhance the drug solubility of poorly soluble 
drug  
➢ To masking the taste of bitter drug  
➢ To obtain required release profile  
➢ To improve drug stability  
Advantages of solid dispersion (1,16,21,22,24, 25) 
Solid dispersion is one of the advantageous technique for 
enhancement of solubility of poorly soluble drug 
consequently the rate of dissolution and the 
bioavailability drug. 
Particles with reduced particle size 
The drug particle size can reduce into molecular levels 
due to the preparation of solid dispersions.(21) After 
dissolution of carrier the drug get dispersed in the 
dissolution medium which increase the surface area of 
drug to the dissolution media which results an increased 
rate of dissolution consequently increase the 
bioavailability of drug.(1,22) 
Particles with better wettability: 
The enhancement in the solubility of the drug is 
associated with the wettability of drug which may 
increase by using surface active carriers such as cholic 
acid and bile salts.(24,25) 
Particles with higher porosity 
Solid dispersion have high porous structure and porosity 
depend on the properties of the carrier used.(25) Solid 
dispersion can be prepared by linear and reticular 
polymer. Comparatively linear polymer shows higher 
porosity. (21,22). 
Drugs in amorphous state  
 Amorphous state of drug require less or no energy to 
breakup the crystal lattice during the process of 
dissolution. Hence it shows higher degree of solubility 
than the crystalline state of drug.(1) 
Aggalomeration:  
The risk of drug particles agglomeration in the 
dissolution media was reduced by using surfactants or 
emulsifiers which improve the rate of dissolution of 
drug.(21) 
Limitations of solid dispersion (1,24) 
Limitations of solid dispersion involve 
i. The chemical and physical stability of drugs 
and vehicles, 
ii. Scale-up of manufacturing processes 
iii. Formulation of solid dispersions into the 
dosage form and 
iv. Reproducibility of its physicochemical  
properties 
Mechanism of drug release from solid dispersions 
(1,7,21,22,24,26,27) 
Drug release from the solid dispersion was observed by 
two mechanisms 
A) Carrier-controlled Release 
B) Drug-controlled Release 
A) Carrier-controlled release 
Corrigan (1986) suggested carrier-controlled dissolution 
in which the inert carrier control the rate of dissolution 
of drug. Further, Dubois and Ford finding supported to 
this work (1985) who noted that the rate of dissolution of 
drugs in a single carrier, prepared under comparable 
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conditions, were identical in most cases. This again 
shows that it is the rate of dissolution of the carrier 
which dominate the process and not by the rate of 
dissolution of drug. In this case, when solid dispersion 
disperse into water, due to hydrophilic property of 
carrier it dissolve or absorb water rapidly and form 
concentrated layer of carrier. If the drug dissolves in this 
layer and the viscosity of this layer is high enough to 
prevent the diffusion of the drug through it, the rate 
limiting step will be the diffusion of the carrier into the 
bulk phase and this mechanism is carrier-controlled 
release. (1,24,26) 
B) Drug-controlled Release 
Nystrom and Sjokvist (1991) measured the griseofulvin 
particle size released from the dispersions which prove 
that the enhancement in the rate of dissolution was a 
directly related to the released particle size. Further, 
Craig and Sjokvist-Saers (1992) used a drugs 
homologous series and authors suggested that there was 
a linear relationship between the intrinsic dissolution 
rate of the model drugs in the dispersions and the drug 
solubility, clearly link with the drug properties (and not 
the polymer) to the rate of dissolution;whichhelps to  
refer such behavior as drug  controlled dissolution.(1,26) 
Here the drug is sparingly soluble or insoluble in 
diffusion layer, released as solid particles and dissolution 
rate will associated with the drug particle properties like 
drug solubility, polymorphic state and  particle 
size.(1,24) 
 
METHOD FOR PREPARATION OF SOLID 
DISPERSION(1,3,6,7,8,9,15,21,28,29,30) 
 
 
Fig. no.2: Preparation method for Solid dispersion 
 
There are three major method of manufacturing of solid 
dispersions viz; melting method, solvent evaporation 
method and melt solvent method. Mostly melt method 
and solvent evaporation method are used.  
Melting method 
Sekiguchi et al. is the first who use a melting method or 
fusion method consisting oftogether melting the carrier 
and drug over the temperature of eutectic point, which is 
the lowest possible melting point of the mixture. Then 
the melted liquid was cooled or solidified by several 
processes like ice bath agitation, immersion in liquid 
nitrogen, solidify in petri dishes at room temperature 
inside a dessicator or spreading on plates placed over dry 
ice.(8,21)Then obtained mass of solid is crushed, then 
pulverized and sieved. (1) This method does not need 
any solvent is the main advantage of this method  and 
the important requirement of this method is carrier and 
drug miscibility in their molten state to form a 
homogenous mixture.(21) The limitation of these 
method are i) due to the use of high temperatures drug 
degradation may occur. ii) carrier and drug incomplete 
miscibility occurs because of polymeric carrier shows 
high viscosity in their molten state. iii) during cooling 
the phase separation may occur due to change in drug–
carrier miscibility. (8,30) To avoid such limitations of 
melting method various modified methods like hot-stage 
R. Bhaskar et al.  / Indian J. Pharm. Biol. Res.,2018; 6(2):43-52 
 
Research Article                                                                                                                                                                                       48 
 
extrusion, MeltrexTM and  melt agglomeration  were 
introduced.(8) 
 
Fig. no.3: Flow diagram of melting method 
 
1.Hot-stage extrusion 
In recent years, hot melt extrusion has become the most 
common method used for the manufacturing of solid 
dispersions. In this method the carrier and drug are 
simultaneously mixed, heated, melted, homogenized and 
extruded in a form of rods, tablets,  milled, or pellets. It 
is more advantageous than other melting method 
because it decrease the degradation risk of thermolabile 
drugs due the low residence time of the carrier and drug 
in the extruder at elevated temperature and method is 
also efficient, continuous, easy scale up and produce 
higher thermodynamic stability products than other 
methods. (8,21) 
 
Fig.no.4: Flow diagram of Hot-stage extrusion 
 
2. MeltrexTM 
 It is a patented solid dispersions preparation process 
based on the hot melt extrusion principle. It associated 
with the special extruder having twin screw and two 
independent hoppers  which can vary the temperature 
over a broad range which reduced residence time of the 
drug in the extruder and avoid thermal stress to the drug 
and excipients. It also protect the oxidation and 
hydrolysis of susceptible drugs by complete removal of 
oxygen and moisture from the mixture.(8) 
3. Melt agglomeration 
Melt agglomeration allows the manufacturing of solid 
dispersions in conventional high shear mixers. In this 
technique binder act as carrier and solid dispersion 
prepared by adding the drug with molten carrier to the 
heated excipients at a temperature within or above the 
melting range of the carriers. Rotary processor might be 
preferable to produce stable solid dispersions by melt 
agglomeration because higher binder content can be 
incorporated in the agglomerates and the temperature 
can be more easily controlled. (1,3)  
Solvent Evaporation 
This method is also known as solvent method in which 
solid dispersions can be formed by the evaporation of 
solvent from the drug and carrier solution.(21) In this 
method volatile solvent which dissolve the maximum 
amount of  drug–carrier physical mixture and solvent 
having low boiling point like methanol, ethanol, 
dichloromethane, acetone and chloroform or their 
mixtures are chosen for the shorten solvent removal 
process.(27) This method overcome the main limitation 
of melting method that is the thermal decomposition of 
drugs or carriers at high temperature and due to which a 
few polymers used as carriers in the melting 
method.(1,21) The disadvantages of this method are 
difficulty in removing residual solvent which may cause 
toxicity, finding a appropriate non-toxic solvent or their 
mixture in which drug and carrier are  dissolve and cost 
of production is high.(6,21,29) For these reasons, hot 
melt extrusion method is more preferable than solvent 
method. A rapid solidification method is always 
preferred and therefore there are various methods 
developed for fast solvent removal such as rotary 
evaporation, freeze drying, spray drying, supercritical 
anti-solvent, co-precipitation, electrostatic spinning, 
fluid-bed coating(21) 
 
Fig. no.5: Flow diagram of Solvent Evaporation 
 
1. Rotary Evaporation 
The risk of phase separation is avoid by using rotary 
evaporation method at a moderate temperature and also 
avoid the drugs and carriers degradation at high 
temperature. The final solid dispersions are stored in a 
vacuum desiccator after solvent evaporation process, for 
removal of complete residual solvent. Though the 
method are easy to perform but the processes are time 
consuming.(21) 
 
Fig. no.6: Flow diagram of Rotary Evaporation 
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2. Freeze Drying 
It is also known as Lyophilization technique. In this 
method carrier and drug dissolve in same solvent and 
immerse the solution into the liquid nitrogen until it 
frozen fully. Lyophilized molecular dispersion is obtain 
after lyophilization of frozen solution.(1,27) The most 
important advantage of the system is that it reduces the 
chances of drug degradation and phase separation by 
operating the system at low temperature. The 
disadvantage of the system is difficult to maintain the 
organic solvents into the frozen state during sublimation 
due to low freezing temperature of solvent.(21,27) 
 
Fig. no.7: Flow diagram of Freeze drying 
 
3. Spray drying 
Spray drying is the most common and  an efficient 
evaporation method for preparation of  solid dispersion 
because it consist of rapid evaporation solvent to 
minimize the chances of phase separation and forms 
more homogenous system.(3,21) In this method drug–
carrier solutions were atomized  into fine droplets and 
sprayed  into a stream of heated gas flow to remove the 
solvent. Rapid evaporation of solvent occurs due to large 
specific surface area of droplets and obtain the fine 
particles of solid dispersion within seconds.(21,27) 
Particle size reduction and rapid evaporation are  the 
main advantages of this technique. The particle size of 
solid dispersion by this method is directly depend on the 
size of droplets which can be changed by the atomizer 
easily.(27) 
 
Fig. no.8: Flow diagram of Spray drying 
 
4. Supercritical anti-solvent (SAS) 
In this method supercritical carbon dioxide (CO2) used 
as a solubilizing solvent or anti-solvent. When CO2 used 
as a solvent, dissolve the drug and carrier in supercritical 
CO2 and sprayed it through a nozzle into an expansion 
vessel at lower pressure. The rapid nucleation is occurs 
due to the rapid expansion of the dissolved drugs and 
carriers, leading to form the particles of solid dispersions 
with a desirable size distribution in a very quick time. 
When using supercritical CO2 as anti-solvent, it is 
introduce into the nozzle simultaneously with solution of 
drug and carrier in an organic solvent. When the solution 
is sprayed, the precipitation of solid dispersion occurs 
due to is rapid extraction of solvent by the supercritical 
CO2.(21) 
 
Fig.no.9: Flow diagram of SAS 
 
5. Co-precipitation  
In this method, a drug and carrier are completely 
dissolved in an organic solvent.The precipitation of the 
drug and carrier occurs after drop wise addition of an 
anti-solvent in the solution. Then filtered the resulting 
suspension and washed it  to remove residual solvents. 
The  final co-precipitated material forms after filtration 
and drying is called as microprecipitated bulk powder 
(MBP ) which is a solid dispersion of the drug and 
carrier.(3,21) The advantages of this method are it 
reduce the risk of phase separation, it does not require 
high temperature which may cause degradation of the 
drug or carrier and the less volatile solvents can be 
used.(27) 
 
Fig. no.10: Flow diagram of Co-precipitation 
 
6. Electrostatic spinning  
Electrostatic spinning is a combination of 
nanotechnology and solid dispersion technology.(4) In 
which solid fibers are produced from a polymeric fluid 
stream solution or melt delivered through a millimeter-
scale nozzle.(1,21) In this method, a drug–polymer 
solution is placed into a spinneret connected with a 
microsyringe pump and a high voltage was  applied 
between 5 and 30 kV to the needle tip for inducing a 
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charge on the surface of the solution and fixed electrical 
potential is also applied. When electrical forces 
overcome the surface tension of the solution at the air 
interface, polymer jets are ejected. Due to applied 
electric field the jet get accelerates and the solvent 
evaporates quickly to form fibers at micron or submicron 
diameter which are collected on the screen. This 
collected fibers can be used in oral dosage forms.(21,25) 
The rapid and efficient solvent evaporation leading to 
the formation of amorphous dispersions which shows 
improved dissolution rate of incorporated drug in these 
fibers is the main advantage of this method.(21) 
 
Fig. no.11: Flow diagram of Electrostatic spinning 
 
7. Fluid-bed coating 
In this method carrier and drug dissolve in common 
solvent and this solution was sprayed onto 
the surface of nonpareil pellet in the fluid-bed coater 
through a nozzle. Co-precipitate deposited 
simultaneously on the surface of nonpareil pellets after 
evaporation of solvent by drying airflow. These solid 
dispersions pellets or granules can be directly used for or 
encapsulating into capsules or tableting.(21) 
 
Fig. no.12: Flow diagram of Fluid-bed coating 
 
Melting solvent method 
This method is combination of both solvent method and 
melting method. Firstly drug is dissolve in suitable 
solvent and then mixed with molten carrier after that 
evaporation of solvent and solidifies to form solid 
dispersions. The advantage of this method is that it 
avoids the risk of thermal degradation of drug. (21) 
 
Fig.no.13: Flow diagram of Melting solvent method 
 
Method of preparation for solid dispersion are shown in 
fig.2 From this listed method spray drying and hot melt 
extrusion are most preferable methods due to their high 
scalability and applicability.(21) 
 
Characterization of solid dispersion(1,9) 
Various method for characterization of solid dispersion 
are mention below 
Physical structure 
• Scanning electron microscopy 
• Raman microscopy 
• Atomic force microscopy 
• Surface properties 
• Surface area analysis 
Drug -carrier miscibility 
• Powder X-ray diffraction 
• Hot stage microscopy 
• Differential scanning calorimetry 
Stability 
• DSC (Tg, Temperature recrystallization) 
• Humidity studies 
• Isothermal Calorimetry 
• Saturated solubility studies 
Amorphous content 
• Polarised light optical microscopy 
• Powder X-ray diffraction 
• DSC (MTDSC) 
Dissolution enhancement 
• Dissolution 
• Dynamic solubility 
• Intrinsic dissolution 
• Intrinsic dissolution 
Practical limitation in solid dispersion 
technique(1,22,31) 
1. Problem related with the dosage form development 
A. Poor flow and compressibility: 
Solid dispersion shows difficulty in pulverization and 
sieving. It also shows poor stability and compressibility. 
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To overcome such problem in- situ drug granulation 
method  is  used.  
B. Sticking of granules of solid dispersion to die and 
punches: 
Sticking was observed during compression to die and 
punches. This problem can be solve by using the small 
pieces of grease proof paper which placed between metal 
surface and granules. Hence the direct contact between 
granules and metal surface was avoided. 
2. Problem related with scale up and manufacturing 
A. During cooling chance of moisture condensation over 
solid dispersion: 
There is chance of moisture condensation over solid 
dispersion during evaporation. This problem can be 
overcome by using the surface moving belt or rotating 
belt were the continuous cooling operation is done. 
B. Reproducibility of physicochemical properties: 
The preparation conditions like heating rate, maximum 
temperature used, cooling rate and method, pulverization 
method, and particle size shows great influence on the 
physicochemical properties of solid dispersions formed. 
3. Problem related with stability 
Solid dispersion prepared by the hot melt method, a 
certain fraction of drug may remain molecularly 
dispersed in carrier if such  extent of drug is high it may 
give rise to phase separation i.e. the crystalline and 
amorphous phase are get separate to avoid this some 
polymer like HPMCAC, HPMC, PVP are used now days 
. The polymer acts as a stabilizer in the preparation of 
solid dispersion by retarding crystallization of drug at 
low humidity and the preventing mechanism of 
crystallization is reducing the nucleation rate. 
Conclusion 
Nowadays, enhancing the solubility of poorly water 
soluble drug for enhancement in their bioavailability is 
major challenge for formulation scientists. So solid 
dispersion is one of the better technique which is used 
for improvement of solubility of poorly water soluble 
drugs. But it require to overcome some problem related 
to flow properties and the stability of drug.  It also 
require some research for better implementation on 
industrial scale as it one of the better technique for 
enhancing the solubility of poorly soluble drugs.  
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